Alendronate Sodium/Colecalciferol

阿仑膦酸钠/胆骨化醇

Report date: 2022/08/16 20:00:19

Base Information

Drug NameAlendronate Sodium/Colecalciferol
Drug Alias Name胆骨化醇/阿仑膦酸钠alendronic acid / colecalciferolAlendronate Sodium Trihydrate and ColecalciferolAlendronate Sodium Trihydrate/ColecalciferolCholecalciferol/Alendronate Sodium +[10
ClassificationSmall molecules
Mechanisms of ActionOsteoclasts inhibitorsVitamin D receptor antagonists
TargetsVitamin D receptor
Therapy Area/IndicationsVitamin D DeficiencyOsteoporosis, PostmenopausalOsteoporosis
Global Approved IndicationsOsteoporosis, PostmenopausalOsteoporosis
Approved Indications in ChinaOsteoporosis, PostmenopausalOsteoporosis
Original Approved Country/TerritoryUnited States
Original Approved Date2005/04/07
Country/TerritoryUnited StatesEUMainland China
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active IndicationsOsteoporosis, PostmenopausalOsteoporosis
Inactive IndicationsVitamin D Deficiency

Other Information

ATC CodeM05BB03
Related LinksKEGG